Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small-cell Lung Cancer

This randomized phase 2 study demonstrated promising clinical synergism between pemetrexed and intercalated erlotinib in patients with unselected nonsquamous non–small-cell lung cancer (NSCLC) as second-line therapy. EGFR (epidermal growth factor receptor) genotyping by Sequenom multiplex oncogenoty...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lung Cancer
Main Authors: Li, Tianhong, Piperdi, Bilal, Walsh, William V., Kim, Mimi, Beckett, Laurel A., Gucalp, Rasim, Haigentz, Missak, Bathini, Venu G., Wen, Huiyu, Zhou, Kaili, Pasquinelli, Patricia B., Gajavelli, Srikanth, Sreedhara, Meera, Xie, Xianhong, Lara, Primo N., Gandara, David R., Perez-Soler, Roman
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497702/
https://ncbi.nlm.nih.gov/pubmed/27919627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2016.10.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados